logo

17.16

17.16 (-0.11%)

As of Mar 06, 2024

Iovance Biotherapeutics, Inc. [IOVA]

Source: 

Company Overview

Iovance Biotherapeutics, Inc is a clinical-stage biopharmaceutical company pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient.

CountryUnited States
Headquarterssan carloscalifornia
Phone Number(650) 260-7120
Industry
manufacturing
CEOFrederick G. Vogt
Websitewww.iovance.com